1. AHRO : Austin Health Research Online

Chun Yew Fong

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Chun Yew Fong
Full Name
Fong, Chun Yew
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Date Issued:  [2020 TO 2021]

Results 1-4 of 4 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
1Jun-2021Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative.Corboy, Greg; Othman, Jad; Lee, Linda; Wei, Andrew; Ivey, Adam; Blombery, Piers; Agarwal, Rishu ; Fong, Chun Yew ; Brown, Anna; Scott, Hamish; Grove, Carolyn; Louw, Alison; Enjeti, Anoop; Iland, Harry; Paul, Cheryl; Bohlander, Stefan; Kakadia, Purvi; Horan, Martin; Stevenson, William
2Mar-2021Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia.Tiong, Ing S ; Dillon, Richard; Ivey, Adam; Teh, Tse-Chieh; Nguyen, Phillip; Cummings, Nicholas; Taussig, David C; Latif, Annie-Louise; Potter, Nicola E; Runglall, Manohursingh; Russell, Nigel H; Raj, Kavita; Schwarer, Anthony P ; Fong, Chun Yew ; Grigg, Andrew P ; Wei, Andrew H
3Oct-2020Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.Chua, Chong Chyn ; Roberts, Andrew W; Reynolds, John; Fong, Chun Yew ; Ting, Stephen B; Salmon, Jessica M; MacRaild, Sarah; Ivey, Adam; Tiong, Ing Soo; Fleming, Shaun; Brown, Fiona C; Loo, Sun; Majewski, Ian J; Bohlander, Stefan K; Wei, Andrew H
4Oct-2020Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia.Ryland, Georgina L; Barraclough, Allison ; Fong, Chun Yew ; Fleming, Shaun; Bajel, Ashish; Hofmann, Oliver; Westerman, David; Grimmond, Sean; Blombery, Piers